BACKGROUND: Maternal cytomegalovirus (CMV) and rubella infections have adverse neonatal outcomes. Basic epidemiological data concerning CMV and rubella is necessary for health planners and care providers. METHODS: A cross sectional study was conducted at El-Rahad hospital, Sudan to investigate seroprevalence of CMV and rubella infections and associated possible risk factors among pregnant women. Structured questionnaires were used to gather socio-demographic data and ELISA was used to detect CMV and rubella infections using IgG and IgM. RESULTS: Out of 231 pregnant women, 167 (72.2%) and 151 (65.3%) were CMV-IgG and rubella-IgG positive, respectively. Only 6 (2.5%) and 8 women (3.4%) were CMV-IgM and rubella-IgM positive, respectively. While, high parity (OR = 14.7, 95%CI = 1.7 - 123.6; P = 0.01] and illiteracy (OR = 3.0, CI = 1.4 - 6.5; P = 0.004) were significantly associated with seropostive CMV-IgG in multivariate analysis, none of the other obstetrical and medical characteristics were significantly associated with CMV or rubella infections. CONCLUSION: CMV prevalence was 72.2% and rubella susceptibility among pregnant women was 34.6%. Rubella vaccine and routine screening for rubella and CMV should be introduced for pregnant women in this setting. Further research is needed.
BACKGROUND:Maternal cytomegalovirus (CMV) and rubella infections have adverse neonatal outcomes. Basic epidemiological data concerning CMV and rubella is necessary for health planners and care providers. METHODS: A cross sectional study was conducted at El-Rahad hospital, Sudan to investigate seroprevalence of CMV and rubella infections and associated possible risk factors among pregnant women. Structured questionnaires were used to gather socio-demographic data and ELISA was used to detect CMV and rubella infections using IgG and IgM. RESULTS: Out of 231 pregnant women, 167 (72.2%) and 151 (65.3%) were CMV-IgG and rubella-IgG positive, respectively. Only 6 (2.5%) and 8 women (3.4%) were CMV-IgM and rubella-IgM positive, respectively. While, high parity (OR = 14.7, 95%CI = 1.7 - 123.6; P = 0.01] and illiteracy (OR = 3.0, CI = 1.4 - 6.5; P = 0.004) were significantly associated with seropostive CMV-IgG in multivariate analysis, none of the other obstetrical and medical characteristics were significantly associated with CMV or rubella infections. CONCLUSION: CMV prevalence was 72.2% and rubella susceptibility among pregnant women was 34.6%. Rubella vaccine and routine screening for rubella and CMV should be introduced for pregnant women in this setting. Further research is needed.
Authors: H H Handsfield; S H Chandler; V A Caine; J D Meyers; L Corey; E Medeiros; J K McDougall Journal: J Infect Dis Date: 1985-02 Impact factor: 5.226
Authors: P Plans; F de Ory; M Campins; E Álvarez; T Payà; E Guisasola; C Compte; K Vellbé; C Sánchez; M J Lozano; I Aran; A Bonmatí; R Carreras; M Jané; L Cabero Journal: Eur J Clin Microbiol Infect Dis Date: 2015-02-10 Impact factor: 3.267
Authors: Maria Lisa Odland; Kristin M Strand; Svein Arne Nordbø; Siri Forsmo; Rigmor Austgulen; Ann-Charlotte Iversen Journal: BMJ Open Date: 2013-09-27 Impact factor: 2.692
Authors: Berno Mwambe; Mariam M Mirambo; Stephen E Mshana; Anthony N Massinde; Benson R Kidenya; Denna Michael; Domenica Morona; Charles Majinge; Uwe Groß Journal: BMC Pregnancy Childbirth Date: 2014-03-03 Impact factor: 3.007
Authors: Aliasgher M Saajan; Mramba Nyindo; Joshua G Gidabayda; Mohammed S Abdallah; Shaneabbas H Jaffer; Aliasgher G Mukhtar; Tima M Khatibu; Rune Philemon; Grace D Kinabo; Blandina T Mmbaga Journal: East Afr Health Res J Date: 2017-07-01